Paper5337283
Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.
Elion GB. Fed Proc, 1967. Cited by 339 papers, by iCite.
Cite this record
ConductScience Library. Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues. Papers, record 5337283. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5337283
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunosuppressive Agents | Major topic |
| Purines | Major topic |
| Animals | |
| Humans |
Source PubMed
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 339 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39737929 | Design of an equilibrative nucleoside transporter subtype 1 inhibitor for pain relief. | Nat Commun | 2024 | https://conductscience.org/library/papers/39737929 | PubMed |
| 28278299 | Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism. | PLoS One | 2017 | https://conductscience.org/library/papers/28278299 | PubMed |
| 24824603 | In vitro oxidative metabolism of 6-mercaptopurine in human liver: insights into the role of the molybdoflavoenzymes aldehyde oxidase, xanthine oxidase, and xanthine dehydrogenase. | Drug Metab Dispos | 2014 | https://conductscience.org/library/papers/24824603 | PubMed |
| 24021350 | Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4). | Biochem Pharmacol | 2013 | https://conductscience.org/library/papers/24021350 | PubMed |
| 23678408 | Simultaneous Determination of 6-Mercaptopurine and its Oxidative Metabolites in Synthetic Solutions and Human Plasma using Spectrophotometric Multivariate Calibration Methods. | Bioimpacts | 2011 | https://conductscience.org/library/papers/23678408 | PubMed |
| 23437289 | Gene expression and thiopurine metabolite profiling in inflammatory bowel disease - novel clues to drug targets and disease mechanisms? | PLoS One | 2013 | https://conductscience.org/library/papers/23437289 | PubMed |
| 21239472 | 6-Thioguanine reactivates epigenetically silenced genes in acute lymphoblastic leukemia cells by facilitating proteasome-mediated degradation of DNMT1. | Cancer Res | 2011 | https://conductscience.org/library/papers/21239472 | PubMed |
| 19214663 | Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment. | J Gastroenterol | 2009 | https://conductscience.org/library/papers/19214663 | PubMed |
| 18506437 | Clinical pharmacology and pharmacogenetics of thiopurines. | Eur J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18506437 | PubMed |
| 17881236 | Novel C2-purine position analogs of nitrobenzylmercaptopurine riboside as human equilibrative nucleoside transporter 1 inhibitors. | Bioorg Med Chem | 2007 | https://conductscience.org/library/papers/17881236 | PubMed |
| 17662091 | IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations. | Br J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/17662091 | PubMed |
| 17636949 | Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors. | J Med Chem | 2007 | https://conductscience.org/library/papers/17636949 | PubMed |
| 17511860 | Preferential inhibition of xanthine oxidase by 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purine thiol. | BMC Biochem | 2007 | https://conductscience.org/library/papers/17511860 | PubMed |
| 16267626 | The thiopurines: an update. | Invest New Drugs | 2005 | https://conductscience.org/library/papers/16267626 | PubMed |
| 14984260 | Bioavailability prediction based on molecular structure for a diverse series of drugs. | Pharm Res | 2004 | https://conductscience.org/library/papers/14984260 | PubMed |
| 7805176 | Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7805176 | PubMed |
| 7593462 | Immunobiology and immunopharmacology of organ allograft rejection. | J Clin Immunol | 1995 | https://conductscience.org/library/papers/7593462 | PubMed |
| 7437011 | An enumerative assay of purine analogue resistant lymphocytes in women heterozygous for the Lesch-Nyhan Mutation. | Biochem Genet | 1980 | https://conductscience.org/library/papers/7437011 | PubMed |
| 7259957 | Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7259957 | PubMed |
| 7192152 | Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7192152 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5337283
GET https://conductscience.org/api/papers/v1/5337283/cited_by?page=2